Judith Tam ALK Positive Non-Small Cell Lung Cancer Research Initiative Team Joins ALKtALK(3/26/23)
When a patient with ALK-positive lung cancer receives a diagnosis, typically targeted therapy is the fist line of treatment. But what happens when the cancer progresses and that treatment is no longer working? The University of Michigan Judith Tam ALK Positive Non-Small Cell Lung Cancer Research Initiative seeks to help ALK-positive patients find the best path forward. The overarching purpose of the project being to foster rapid adoption of key discoveries that will directly enhance the quality and length of patient's lives. Since its inception in late 2021, the initiative has made extraordinary progress towards it objectives and continues to accelerate forward. This initiative is made possible by a generous $7.6M gift from the Judith and Richard Tam Foundation.
View this ALKtALK to hear from the outstanding oncologists leading this critical project. Watch to learn about the project's initiative, where it is now and where its going. A question and answer session takes place following the presentation and is moderated by ALK Positive, Inc multi-medical committee member Jeffrey Sturm.
-
Category
No comments found